Latino patients with cancer face a challenging survivorship journey. Find new ways to address these challenges at UT Health San Antonio’s webinar, “How to Support Latino Cancer Survivors,” at 11 a.m. Central Time on Monday, July 15.
Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
